It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: jhn7537
originally posted by: jimmyx
the CEO was on CNBC this morning, and the host told her that the entire EPIPEN costs about 4 dollars to manufacture...5 years ago it sold for 60 dollars, and in the following years climbed about 100 dollars a year to 608 dollars this year....they can't stop themselves from being so greedy, even to the point that the government will step in and regulate....and then BIG PHARMA will bitch and moan about regulations hurting their business, and of course they will blame government overreach.....F them.
They are essentially forcing our hand to regulate their whole industry.. Either less patent protection for more competition or regulation.. has to be one or the other.
originally posted by: Ash614
She admits openly that the list price was never intended to be sold at retail cost but subsidized by insurance benefits. Now we have high deductible plans which shows the public the real cost and she is frustrated? Then to make matters worse she admits Americans pay higher cost because we subsidize the world's drug cost. And that's a good thing?! Seriously our ruling class sounds more each day like Marie Antoinette. Poor CEO is just as upset as the parents of children because her rigged system is being exposed.
originally posted by: seasonal
a reply to: ketsuko
This whole medical industry is a mess.
In this case are we to believe the costs associated with manufacturing this went up 400-500% in 6-10 years? This company doesn't develop drugs, they acquire rights and make/sell them. Is it true the drug companies spend more on marketing than they do on R and D ?
In 2011, the U.S. spent $8,508 per capita in health care expenditures, compared with $3,405 per capita in the U.K., which was the country with the highest ranked health care system overall.